Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered network hub connectivity after acute LSD administration
Felix Müller, Patrick C. Dolder, André Schmidt, et al.
NeuroImage Clinical (2018) Vol. 18, pp. 694-701
Open Access | Times Cited: 161

Showing 26-50 of 161 citing articles:

More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics
Marco Aqil, Leor Roseman
Neuropharmacology (2022) Vol. 223, pp. 109300-109300
Open Access | Times Cited: 44
Effective Connectivity of Functionally Anticorrelated Networks Under Lysergic Acid Diethylamide
Devon Stoliker, Leonardo Novelli, Franz X. Vollenweider, et al.
Biological Psychiatry (2022) Vol. 93, Iss. 3, pp. 224-232
Open Access | Times Cited: 38
A whole-brain model of the neural entropy increase elicited by psychedelic drugs
Rubén Herzog, Pedro A. M. Mediano, Fernando E. Rosas, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 32
Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
M. Ishrat Husain, Nicole Ledwos, Elise Fellows, et al.
Frontiers in Psychiatry (2023) Vol. 13
Open Access | Times Cited: 30
The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity
Peter Bedford, Daniel J. Hauke, Zheng Wang, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 8, pp. 1175-1183
Open Access | Times Cited: 24
Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential
Josh Allen, Shannon Dames, Claire J. Foldi, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 671-685
Closed Access | Times Cited: 13
The mechanistic divide in psychedelic neuroscience: An unbridgeable gap?
Bryan Barksdale, Manoj K. Doss, Gregory A. Fonzo, et al.
Neurotherapeutics (2024), pp. e00322-e00322
Open Access | Times Cited: 13
Antidepressant and anxiolytic effects of activating 5HT2A receptors in the anterior cingulate cortex and the theoretical mechanisms underlying them – A scoping review of available literature
Leonor Miranda
Brain Research (2024) Vol. 1846, pp. 149226-149226
Open Access | Times Cited: 13
Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin
Devon Stoliker, Leonardo Novelli, Franz X. Vollenweider, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 1, pp. 57-66
Open Access | Times Cited: 12
Exploring mechanisms of psychedelic action using neuroimaging
David Erritzøe, Christopher Timmermann, Kate Godfrey, et al.
Nature Mental Health (2024) Vol. 2, Iss. 2, pp. 141-153
Closed Access | Times Cited: 11
Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management
Natalie Strand, Madeline Whitney, Brooks Johnson, et al.
Current Pain and Headache Reports (2025) Vol. 29, Iss. 1
Closed Access | Times Cited: 1
Decreased directed functional connectivity in the psychedelic state
Lionel Barnett, Suresh Muthukumaraswamy, Robin Carhart‐Harris, et al.
NeuroImage (2019) Vol. 209, pp. 116462-116462
Open Access | Times Cited: 69
RETRACTED ARTICLE: A mechanistic model of the neural entropy increase elicited by psychedelic drugs
Rubén Herzog, Pedro A. M. Mediano, Fernando E. Rosas, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 58
Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects
Friederike Holze, Urs Duthaler, Patrick Vizeli, et al.
British Journal of Clinical Pharmacology (2019) Vol. 85, Iss. 7, pp. 1474-1483
Open Access | Times Cited: 55
Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders
Lea J. Mertens, Katrin H. Preller
Pharmacopsychiatry (2021) Vol. 54, Iss. 04, pp. 176-190
Closed Access | Times Cited: 52
Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings
Carla Pallavicini, Federico Cavanna, Federico Zamberlán, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 4, pp. 406-420
Closed Access | Times Cited: 46
Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
Friederike Holze, Isidora Avedisian, Nimmy Varghese, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 46
Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity
James E. Glazer, Conor H. Murray, Robin Nusslock, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 2, pp. 418-426
Closed Access | Times Cited: 35
Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration
Mihai Avram, Felix Müller, Helena Rogg, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2022) Vol. 7, Iss. 9, pp. 885-894
Open Access | Times Cited: 28
Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs
Farah Zia, Michael H. Baumann, Sean J. Belouin, et al.
Neuropharmacology (2023) Vol. 233, pp. 109528-109528
Open Access | Times Cited: 20
Recent advances in the neuroscience of spontaneous and off-task thought: implications for mental health
Aaron Kucyi, Julia W. Y. Kam, Jessica R. Andrews‐Hanna, et al.
Nature Mental Health (2023) Vol. 1, Iss. 11, pp. 827-840
Open Access | Times Cited: 20
Mindfulness meditation and psychedelics: potential synergies and commonalities
Paweł Holas, Justyna Kamińska
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1398-1409
Open Access | Times Cited: 16
Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy
Yasmin Schmid, Anya K. Bershad
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 9, Iss. 5, pp. 490-499
Open Access | Times Cited: 6
Broadening Your Mind to Include Others: The relationship between serotonergic psychedelic experiences and maladaptive narcissism
Valerie van Mulukom, Ruairi Patterson, Michiel van Elk
Psychopharmacology (2020) Vol. 237, Iss. 9, pp. 2725-2737
Open Access | Times Cited: 49
How everyday sounds can trigger strong emotions: ASMR, misophonia and the feeling of wellbeing
Paul D. McGeoch, Romke Rouw
BioEssays (2020) Vol. 42, Iss. 12
Open Access | Times Cited: 48

Scroll to top